Showing results (1-10 of 146) with videos related to
Sort By:
Pageof 15
Methods in Molecular Medicine|August 25, 2005
Modeling liver fibrosis in rodentsChristothea Constandinou, Neil Henderson, John P IredaleThe American Journal of Pathology|March 4, 2005
Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injuryFiona Oakley, Jelena Mann, Sarah Nailard, et al.The Journal of Clinical Investigation|March 3, 2007
Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organJohn P IredaleClinical and Vaccine Immunology : CVI|July 18, 2008
Measurement of the humoral immune response following an incident human papillomavirus type 16 or 18 infection in young women by a pseudovirion-based neutralizing antibody assayJane Steele, Stuart Collins, Kaisheng Wen, et al.Annals of Hepatology|December 17, 2009
Reversibility of liver fibrosisPrakash Ramachandran, John P IredaleClinical Science (London, England : 1979)|January 31, 2007
Liver fibrosis: cellular mechanisms of progression and resolutionNeil C Henderson, John P IredaleExpert Opinion on Therapeutic Targets|October 8, 2004
Targeted treatments for cirrhosisJonathan A Fallowfield, John P IredaleDigestive Diseases (Basel, Switzerland)|May 16, 2006
Emerging therapies for liver fibrosisAndrew J Fowell, John P IredaleCancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2010
Is human papillomavirus viral load a clinically useful predictive marker? A longitudinal studyChristothea Constandinou-Williams, Stuart I Collins, Sally Roberts, et al.Pageof 15